Pulse Biosciences, Inc. (PLSE)
50.44
-1.81
(-3.46%)
USD |
NASDAQ |
Nov 13, 16:00
50.25
-0.19
(-0.38%)
After-Hours: 19:59
Pulse Biosciences EPS Diluted (Quarterly) : -0.3205 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.3205 |
| June 30, 2026 | -0.3563 |
| March 31, 2026 | -0.2733 |
| December 31, 2025 | -0.2572 |
| September 30, 2025 | -0.2877 |
| June 30, 2025 | -0.2849 |
| March 31, 2025 | -0.2502 |
| December 31, 2024 | -0.3124 |
| September 30, 2024 | -0.2076 |
| June 30, 2024 | -0.1991 |
| March 31, 2024 | -0.1837 |
| December 31, 2023 | -0.2167 |
| September 30, 2023 | -0.1924 |
| June 30, 2023 | -0.2226 |
| March 31, 2023 | -0.2621 |
| December 31, 2022 | -0.247 |
| September 30, 2022 | -0.4855 |
| June 30, 2022 | -0.4444 |
| March 31, 2022 | -0.5807 |
| December 31, 2021 | -0.5202 |
| September 30, 2021 | -0.4823 |
| June 30, 2021 | -0.5787 |
| Date | Value |
|---|---|
| March 31, 2021 | -0.7149 |
| December 31, 2020 | -0.5422 |
| September 30, 2020 | -0.5113 |
| June 30, 2020 | -0.5264 |
| March 31, 2020 | -0.5697 |
| December 31, 2019 | -0.6629 |
| September 30, 2019 | -0.5654 |
| June 30, 2019 | -0.548 |
| March 31, 2019 | -0.4874 |
| December 31, 2018 | -0.5071 |
| September 30, 2018 | -0.6357 |
| June 30, 2018 | -0.5428 |
| March 31, 2018 | -0.5147 |
| December 31, 2017 | -0.53 |
| September 30, 2017 | -0.52 |
| June 30, 2017 | -0.43 |
| March 31, 2017 | -0.23 |
| December 31, 2016 | -0.21 |
| September 30, 2016 | -0.21 |
| June 30, 2016 | -0.23 |
| March 31, 2016 | -0.22 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Accuray, Inc. | 2.911 |
| Orthofix Medical, Inc. | -0.1475 |
| ResMed, Inc. | 2.918 |
| Rockwell Medical, Inc. | -0.5851 |
| Microbot Medical, Inc. | -0.0838 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.05M |
| Revenue (Quarterly) | 0.395M |
| Total Expenses (Quarterly) | 23.45M |
| Enterprise Value | 3.515B |
| Gross Profit Margin (Quarterly) | 18.61% |
| Profit Margin (Quarterly) | -5.84K% |
| Earnings Yield | -2.39% |
| Normalized Earnings Yield | -2.393 |